The BSE Mid-cap Index is trading up 0.39% at 11,114, whereas BSE Small-cap Index is trading up 0.26% at 11,932.
At 9:26 AM, the S&P BSE Sensex is trading at 28,816 up 16 points, while NSE Nifty is trading at 8,751 up 1 points.
The BSE Mid-cap Index is trading up 0.39% at 11,114, whereas BSE Small-cap Index is trading up 0.26% at 11,932.
ONGC, Reliance Industries, Bharti Airtel, Tata Motors and Tata Steel are among the gainers, whereas Welspun Corp, HPCL, PMC Fincorp and BayerCropScience are losing sheen on BSE.
The results are slowly pouring in and attention will be on tech companies today. The fourth quarter is typically a soft quarter for Indian IT companies as client’s freeze their IT budgets for the calendar year and its allocation. The spend is weak but accelerates from Q1. At the broader level, the business environment for offshore vendors is gradually improving with demand from key markets of US and Europe remaining fairly strong. But all that will be reflected in the current quarter (Q1). TCS is expected to post 3%+ qoq organic constant currency growth in Q4 FY15 while Mindtree is likely to report flat revenues in cc terms impacted by ramp‐up deferment in projects at a couple of clients in the Retail & CPG vertical.
Global cues are positive. The Dow rose 0.42% while S&P 500 gained 0.51%. Nasdaq added 0.68%. Asian markets were trading mixed. Japan's Nikkei is down while Hong Kong's Hang Seng index is up.
Rupee is seen firming up as reports indicate banks may be selling dollars following its weakness against the euro. At the same time PSUs are expected to buy dollars which will prevent any undue appreciation in the Indian currency.
Governor Raghuram Rajan will be attending G20 Finance Ministers and Central Bank Governors meetings and World Bank Spring Meetings 2015 at International Monetary Fund, Washington DC. The Prime Minister Narendra Modi meanwhile is touring Canada.
CMI board will meet today to consider issue of equity shares on preferential basis.
The annual rate of inflation, based on monthly WPI, stood at -2.33% (provisional) for the month of March, 2015 (over March, 2014) as compared to -2.06% (provisional) for the previous month and 6.00% during the corresponding month of the previous year. Build up inflation rate in the financial year so far was -2.33% compared to a build up rate of 6.00% in the corresponding period of the previous year.
Nokia said it has agreed to buy Alcatel-Lucent in an all-share transaction that values the smaller French rival at US$16.58 billion, according to reports.Report said that Nokia will give Alcatel-Lucent shareholders 0.55 shares in the combined company for each of their old shares.The deal will be finalised in the first half of 2016, says report.
SpiceJet is further increasing its international services with the addition of two more weekly flights on the Ahmedabad – Muscat sector, taking the total frequency to 5 flights a week. The additional flights are effective from May 13th 2015.
Aurobindo Pharma Ltd has received USFDA Approval for Cefixime for Oral Suspension USP.The approved ANDAs are bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Suprax Oral Suspension USP 100mg/5mL and 200mg/5mL respectively of Lupin Pharmaceuticals Inc.
The BSE Mid-cap Index is trading up 0.39% at 11,114, whereas BSE Small-cap Index is trading up 0.26% at 11,932.
ONGC, Reliance Industries, Bharti Airtel, Tata Motors and Tata Steel are among the gainers, whereas Welspun Corp, HPCL, PMC Fincorp and BayerCropScience are losing sheen on BSE.
The results are slowly pouring in and attention will be on tech companies today. The fourth quarter is typically a soft quarter for Indian IT companies as client’s freeze their IT budgets for the calendar year and its allocation. The spend is weak but accelerates from Q1. At the broader level, the business environment for offshore vendors is gradually improving with demand from key markets of US and Europe remaining fairly strong. But all that will be reflected in the current quarter (Q1). TCS is expected to post 3%+ qoq organic constant currency growth in Q4 FY15 while Mindtree is likely to report flat revenues in cc terms impacted by ramp‐up deferment in projects at a couple of clients in the Retail & CPG vertical.
Global cues are positive. The Dow rose 0.42% while S&P 500 gained 0.51%. Nasdaq added 0.68%. Asian markets were trading mixed. Japan's Nikkei is down while Hong Kong's Hang Seng index is up.
Rupee is seen firming up as reports indicate banks may be selling dollars following its weakness against the euro. At the same time PSUs are expected to buy dollars which will prevent any undue appreciation in the Indian currency.
Governor Raghuram Rajan will be attending G20 Finance Ministers and Central Bank Governors meetings and World Bank Spring Meetings 2015 at International Monetary Fund, Washington DC. The Prime Minister Narendra Modi meanwhile is touring Canada.
CMI board will meet today to consider issue of equity shares on preferential basis.
The annual rate of inflation, based on monthly WPI, stood at -2.33% (provisional) for the month of March, 2015 (over March, 2014) as compared to -2.06% (provisional) for the previous month and 6.00% during the corresponding month of the previous year. Build up inflation rate in the financial year so far was -2.33% compared to a build up rate of 6.00% in the corresponding period of the previous year.
Nokia said it has agreed to buy Alcatel-Lucent in an all-share transaction that values the smaller French rival at US$16.58 billion, according to reports.Report said that Nokia will give Alcatel-Lucent shareholders 0.55 shares in the combined company for each of their old shares.The deal will be finalised in the first half of 2016, says report.
SpiceJet is further increasing its international services with the addition of two more weekly flights on the Ahmedabad – Muscat sector, taking the total frequency to 5 flights a week. The additional flights are effective from May 13th 2015.
Aurobindo Pharma Ltd has received USFDA Approval for Cefixime for Oral Suspension USP.The approved ANDAs are bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Suprax Oral Suspension USP 100mg/5mL and 200mg/5mL respectively of Lupin Pharmaceuticals Inc.
No comments:
Post a Comment